CHRNA5 associated_with peripheral arterial disease
Evidence from:
primary |
all sources
Evidence (1 sources)
CHRNA5 with lung cancer (most recently [34]), lung function [35], airflow obstruction [36], COPD (most recently [37]), and peripheral arterial disease [9]
confidence: 0.95